Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Mannkind Corp
(NQ:
MNKD
)
5.970
-0.110 (-1.81%)
Streaming Delayed Price
Updated: 9:40 AM EDT, Sep 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Mannkind Corp
< Previous
1
2
3
4
5
6
Next >
12 Health Care Stocks Moving In Thursday's Intraday Session
February 24, 2022
Gainers Lantheus Holdings (NASDAQ:LNTH) stock rose 33.3% to $38.46 during Thursday's regular session. The current volume of 3.4 million shares is 876.7% of Lantheus...
Via
Benzinga
44 Stocks Moving In Thursday's Mid-Day Session
February 24, 2022
Gainers Indonesia Energy Corporation Limited (NYSE: INDO) shares climbed 66.7% to $12.55 following a 16% surge on Wednesday. Camber Energy, Inc. (NYSE: CEI) rose 45.2% to $0....
Via
Benzinga
FDA Pushes United Therapeutics-MannKind Tyvaso DPI's Decision Date; United Therapeutics' Q4 Misses Consensus
February 24, 2022
United Therapeutics Corp (NASDAQ: UTHR) and its partner MannKind Corp (NASDAQ: MNKD) have received an FDA information request letter for additional...
Via
Benzinga
MannKind's Debt Overview
August 09, 2021
Shares of MannKind (NASDAQ:MNKD) moved higher by 1.74% in the past three months. Before having a look at the importance of debt, let us look at how much debt MannKind has....
Via
Benzinga
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
August 08, 2021
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 23, 2022
Gainers SCYNEXIS (NASDAQ:SCYX) shares inc...
Via
Benzinga
Executives Buy Over $2.7M Of 4 Penny Stocks
February 03, 2022
Although producer prices in the Eurozone surged 26.2% year-over-year in December, hitting the highest level on record, there were a few notable insider trades.
Via
Benzinga
Recap: MannKind Q3 Earnings
November 09, 2021
MannKind (NASDAQ:MNKD) reported its Q3 earnings results on Tuesday, November 9, 2021 at 04:00 PM. Here's what investors need to know about the announcement. Earnings MannKind...
Via
Benzinga
Wall Street Crime and Punishment: Martin Shkreli, The Self-Destructive Pharma Bro
November 05, 2021
Does crime pay? Wall Street Crime and Punishment is a weekly series by Benzinga's Phil Hall chronicling the bankers, brokers and financial ne’er-do-wells whose ambition...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
October 28, 2021
Gainers Bellerophon Therapeutics (NASDAQ:
Via
Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
November 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces...
Via
Benzinga
46 Biggest Movers From Yesterday
October 19, 2021
Gainers Valneva SE (NASDAQ: VALN) shares surged 39.8% to close at $39.21 on Monday after the company reported VLA2001 met both co-primary endpoints in the Phase 3 pivotal trial...
Via
Benzinga
Mid-Afternoon Market Update: Dow Falls 70 Points; Evolving Systems Shares Spike Higher
October 18, 2021
Toward the end of trading Monday, the Dow traded down 0.20% to 35,223.86 while the NASDAQ rose 0.68% to 14,998.54. The S&P also rose, gaining 0.19% to 4,480.05. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Monday's Intraday Session
October 18, 2021
Gainers Progenity (NASDAQ:PROG) shares increased by 33.17% to $2.85 during Monday's regular session. As of 12:30 EST, Progenity's stock is trading at a volume of...
Via
Benzinga
Why Shares of MannKind Corporation Are Falling This Morning
October 18, 2021
Investors are hyperventilating after a delay for its inhaled medicine.
Via
The Motley Fool
Mid-Day Market Update: Nasdaq Rises 50 Points; Revance Therapeutics Shares Plummet
October 18, 2021
Midway through trading Monday, the Dow traded down 0.05% to 35,275.96 while the NASDAQ rose 0.34% to 14,948.46. The S&P also rose, gaining 0.19% to 4,479.71. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
34 Stocks Moving In Monday's Mid-Day Session
October 18, 2021
Gainers Valneva SE (NASDAQ: VALN) shares jumped 34.6% to $37.75 after the company reported VLA2001 met both co-primary endpoints in the Phase 3 pivotal trial Cov-Compare....
Via
Benzinga
MNKD Stock: The Disappointing FDA News That Has MannKind Shares Diving Today
October 18, 2021
MannKind (MNKD) stock is taking a beating on Monday after releasing an update to investors concerning news from the FDA for Tyvaso DPI.
Via
InvestorPlace
Exposures
Product Safety
Why MannKind Shares Are Falling Today
October 18, 2021
MannKind Corp (NASDAQ: MNKD) is trading significantly lower Monday morning after the company announced the FDA issued a complete response to United Therapeutics regarding the...
Via
Benzinga
Exposures
Product Safety
FDA Declines MannKind - United Therapeutics' Formulated Treprostinil For Lung Disease
October 18, 2021
The FDA has issued a complete response to United Therapeutics Corporation (NASDAQ: UTHR) regarding the marketing application for Tyvaso DPI for pulmonary...
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 18, 2021
Gainers Valneva (NASDAQ:VALN) stock increased by 35.65% to $38.05 during Monday's pre-market session. The market value of their outstanding shares is at $1.8 billion....
Via
Benzinga
Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates
October 01, 2021
Following a mixed month for regulatory approvals, biotech investors now turn toward a month of plenty as far as Food and Drug Administration decisions are concerned. Four new...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
September 29, 2021
Gainers Regencell Bioscience (NASDAQ:RGC)...
Via
Benzinga
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
September 30, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 29) Acceleron Pharma Inc. (...
Via
Benzinga
Exposures
COVID-19
MannKind's Return On Capital Employed Overview
September 22, 2021
According to Benzinga Pro data, during Q2, MannKind (NASDAQ:MNKD) posted sales of $23.28 million. Earnings were up 9.95%, but MannKind still reported an overall loss of $9.03...
Via
Benzinga
United Therapeutics-MannKind's Formulated Tyvaso Shows Benefit In Pulmonary Hypertension Patients
September 07, 2021
United Therapeutics Corporation (NASDAQ: UTHR) has presented new clinical data from the BREEZE study evaluating Tyvaso DPI (treprostinil) in patients with pulmonary...
Via
Benzinga
MannKind Corporation (MNKD) Q2 2021 Earnings Call Transcript
August 12, 2021
MNKD earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
MannKind: Q2 Earnings Insights
August 11, 2021
Shares of MannKind (NASDAQ:MNKD) moved higher by 3.1% in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were unchanged 0.00% year...
Via
Benzinga
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
August 11, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
August 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.